Summary & Overview
HCPCS G9834: Metastatic Disease at Diagnosis
HCPCS Level II code G9834 documents that a patient has metastatic disease at the time of cancer diagnosis. As a clinical descriptor within oncology records, this code supports accurate staging documentation, care planning, and administrative reporting. Nationally, clear documentation of metastatic status is critical for treatment decisions, quality measurement, and claims adjudication across payers.
Payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical meaning, expected settings of use, and the types of payment and policy considerations that typically surround staging and diagnosis codes. The publication summarizes benchmark topics and policy updates relevant to oncology diagnostic coding and identifies the clinical context in which G9834 is applied.
This resource is intended for billing professionals, clinical coders, oncology clinicians, and payer policy analysts seeking a national perspective on how a metastatic-at-diagnosis descriptor is recorded and interpreted within claims and clinical workflows. Data not available in the input.
Billing Code Overview
HCPCS Level II code G9834 indicates patient has metastatic disease at diagnosis. This code is used to document that metastatic disease was present at the time of initial cancer diagnosis and functions as a clinical descriptor associated with oncology care.
-
Service type: Oncology diagnostic/clinical documentation
-
Typical site of service: Oncology clinics, hospital inpatient and outpatient oncology services, and other settings where initial cancer staging or diagnostic documentation occurs
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult diagnosed with a solid tumor where imaging or biopsy at initial presentation demonstrates distant metastatic disease (synchronous metastases). The patient often presents to an oncology clinic or multidisciplinary cancer center following referral from primary care or the emergency department after symptom-driven imaging (e.g., CT chest/abdomen/pelvis, PET/CT). Initial evaluation includes history, physical exam, staging imaging, pathologic confirmation of the primary malignancy and metastatic sites, and discussion of prognosis and treatment planning. Documentation in the medical record that the patient "has metastatic disease at diagnosis" supports use of the billing code G9834 during the initial oncology encounter or staging visit. Typical site of service is an outpatient oncology clinic, ambulatory infusion center, or hospital outpatient department when staging and treatment planning are performed. Clinical workflow steps include: ordering and reviewing staging studies, confirming pathology, recording stage and metastatic status in the problem list and encounter note, establishing goals of care, and coordinating referrals for systemic therapy, radiotherapy, palliative care, or clinical trials. Common modifiers are appended for billing nuances such as bilateral procedures, unusual work effort, or split/shared services when applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |